Ocular Therapeutix (OCUL) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, with introductions of board members, nominees, and key company representatives.

• The meeting was held virtually to maximize stockholder participation, with rules of conduct and participation explained.

Board and executive committee updates

• Board members and nominees for director positions were introduced, including the CEO and Merilee Raines.

Shareholder proposals

• Proposals included election of Class III directors, advisory votes on executive compensation and its frequency, amendment to the 2021 Stock Incentive Plan, and ratification of the accounting firm.